IRE1α: a gatekeeper of chemotherapy-induced immunogenicity in triple-negative breast cancer

Nirmal Robinson; Ruhi Polara; Daniel Thomas

doi:10.1038/s41392-025-02134-w

IRE1α: a gatekeeper of chemotherapy-induced immunogenicity in triple-negative breast cancer

Nirmal Robinson
, Ruhi Polara
, Daniel Thomas

Myeloid Metabolism Group

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Original language	English
Article number	52
Journal	Signal transduction and targeted therapy
Volume	10
Issue number	1
DOIs	https://doi.org/10.1038/s41392-025-02134-w
Publication status	Published or Issued - Dec 2025

ASJC Scopus subject areas

Genetics
Cancer Research

Access to Document

10.1038/s41392-025-02134-w

Cite this

@article{0a501b71692e4530a35d5bfb6451fea3,

title = "IRE1α: a gatekeeper of chemotherapy-induced immunogenicity in triple-negative breast cancer",

author = "Nirmal Robinson and Ruhi Polara and Daniel Thomas",

year = "2025",

month = dec,

doi = "10.1038/s41392-025-02134-w",

language = "English",

volume = "10",

journal = "Signal transduction and targeted therapy",

issn = "2095-9907",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - IRE1α

T2 - a gatekeeper of chemotherapy-induced immunogenicity in triple-negative breast cancer

AU - Robinson, Nirmal

AU - Polara, Ruhi

AU - Thomas, Daniel

PY - 2025/12

Y1 - 2025/12

UR - https://www.scopus.com/pages/publications/85218837684

U2 - 10.1038/s41392-025-02134-w

DO - 10.1038/s41392-025-02134-w

M3 - Article

C2 - 39934100

AN - SCOPUS:85218837684

SN - 2095-9907

VL - 10

JO - Signal transduction and targeted therapy

JF - Signal transduction and targeted therapy

IS - 1

M1 - 52

ER -

IRE1α: a gatekeeper of chemotherapy-induced immunogenicity in triple-negative breast cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this